Registration - Consultant Lobbyist
The Diabetes Care Division of Abbott Laboratories / Mark Jiles, Consultant Lobbyist
Registration Information
Lobbyist name: Mark Jiles, Consultant Lobbyist
Initial registration start date: 2021-02-08
Registration status: Inactive
Registration number: 1588-4037
Associated Lobbying Activity Reports
Total number of Lobbying Activity Reports: 6
Lobbying Activity Reports - last 6 months: 0
Version 3 of 3 (2022-01-31 to 2023-01-31)
Version 3 of 3 (2022-01-31 to 2023-01-31)
Lobbying Information
Details Regarding the Identified Subject Matter |
|||||||
| Will the consultant lobbyist be arranging meetings between a public office holder and the client for the purpose of attempting to influence any of the matters listed: | Yes | ||||||
|
|||||||
BC Ministries/Provincial Entities
- Finance
- Health
- Member(s) of the BC Legislative Assembly
- Mental Health and Addictions
- Parliamentary Secretary for Seniors' Services and Long-Term Care
Contingency Information
- Payment to the consultant lobbyist by the client, in whole or in part, is not contingent on the outcome of this lobbying activity.
- Payment to the consultant lobbyist by the client, in whole or in part, is not contingent on the success in arranging a meeting with public office holders on behalf of the client.
Client Details
Client Contact Information
The Diabetes Care Division of Abbott Laboratories
Address:
#100-4310 Sherwoodtowne Blvd
Mississauga,ON, BC L4Z 4C4
Canada
Website:
https://www.diabetescare.abbott/products.html
Description of Business Activities
The diverse family of Abbott Canada's pharmaceutical, medical, and nutritional products includes a broad range of specialized medicines, medical diagnostic instruments and tests, minimally invasive surgical devices, and a spectrum of nutritional supplements for infants, children and adults.
Contributors to the Lobbying Activity
No person or organization contributed over $1000CDN, within the preceding 12 months, toward the lobbying activity on behalf of the organization that has a direct interest in the outcome of the lobbying activity.
Government Funding in the Last 12 Months
No government funding was requested or received within the preceding 12 months.Other Entities (working together for the purposes of lobbying) Information
The Diabetes Care Division of Abbott Laboratories is not working together with any other entity for the purpose of lobbying.
Affiliates with a Direct Interest in the Outcome
The Diabetes Care Division of Abbott Laboratories does not have any affiliates that could have a direct interest in the outcome of the lobbying activities
Other Persons or Organizations with Direct Interests
The activities of The Diabetes Care Division of Abbott Laboratories are not controlled or directed by another person or organization with a direct interest in the outcome of this undertaking.
Lobbyist Details
Mark Jiles | Has not held any “former public office holder” positions in BC, as defined in the Lobbyists Transparency Act
700 Park Place 666 Burrard Str
Vancouver, BC V6C 2X8
Canada
Relevant Codes of Conduct
The consultant lobbyist does not have in place an undertaking to comply with any relevant codes of conduct.
Political, Sponsorship and Recall Contributions
| Consultant has lobbied, or plans to lobby a member of the Legislative Assembly, including a Minister or Premier, on behalf of this client, on or after 2020-09-21: | Yes | |||||||||||||||
|
||||||||||||||||
Gifts or Benefits Provided to Public Officer Holders
No gifts or benefits were provided to public office holdersIndividuals Hired or Subcontracted to Lobbying on behalf of the Client
- Rob Nagai
- Dennis Chan
Consultant Lobbyist Firm and Address
Firm: Bluestone Government Relations
Suite 1510-1050 West Pender Street
Vancouver, BC V6C 2X8
Canada
Return to Energy, Mines and Low Carbon Innovation in Lobbying Activity Reports in: June 2022
- Date Modified: